Debra J Wallace

Title: Debra J Wallace: Innovator in Pharmaceutical Chemistry

Introduction

Debra J Wallace is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target neurological and psychiatric disorders. With a total of 2 patents, her work has garnered attention for its innovative approaches to drug development.

Latest Patents

Debra's latest patents include a process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide. This invention relates to the preparation of protected piperidine carboxylates that serve as intermediates leading to the beta lactamase inhibitor. Another notable patent is for the preparation of an orexin receptor antagonist, which is directed towards processes for creating a diazepane compound. This compound is useful in treating or preventing neurological and psychiatric disorders where orexin receptors play a role.

Career Highlights

Debra J Wallace is currently associated with Merck Sharp & Dohme Corp., where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions in the pharmaceutical industry.

Collaborations

Throughout her career, Debra has collaborated with notable colleagues, including Carl A Baxter and Edward Cleator. These partnerships have contributed to the success of her projects and the advancement of her inventions.

Conclusion

Debra J Wallace stands out as a key figure in pharmaceutical innovation, with her patents reflecting her commitment to addressing complex medical challenges. Her contributions continue to influence the field and pave the way for future advancements in drug development.